| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/1996 | WO1996000231A1 Anti-sense oligonucleotides for aromatase inhibition |
| 01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 01/04/1996 | WO1996000226A1 Substituted azaindolylidene compounds and process for their preparation |
| 01/04/1996 | WO1996000218A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000212A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 01/04/1996 | WO1996000205A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 01/04/1996 | WO1996000090A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 01/04/1996 | WO1996000080A1 Non-antigenic amine derived polymers and polymer conjugates |
| 01/04/1996 | WO1996000076A1 Use of the enantiomers of oxazophosphorines, e.g. ifosfamide, in anti-tumour therapy, for reducing side-effects |
| 01/04/1996 | WO1996000075A1 Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects |
| 01/04/1996 | WO1996000074A1 Pharmaceutical compositions comprising vitamin-d analogs |
| 01/04/1996 | WO1996000073A1 Treatment of optic neuritis |
| 01/04/1996 | WO1996000068A2 Combination therapy for hiv infection |
| 01/04/1996 | WO1996000066A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 01/04/1996 | WO1996000065A1 Tacrine pharmaceutical compositions |
| 01/04/1996 | WO1996000064A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 01/04/1996 | WO1996000063A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 01/04/1996 | WO1996000062A1 Dopamine d1 agonists for the treatment of dementia |
| 01/04/1996 | WO1996000060A1 Topical compositions comprising n-acetyl-l-cysteine |
| 01/04/1996 | WO1996000059A1 Therapeutic agent for liver regeneration |
| 01/04/1996 | WO1996000058A1 Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| 01/04/1996 | WO1996000057A1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 01/04/1996 | WO1996000047A1 Subcutaneous implant |
| 01/04/1996 | WO1996000016A1 Novel dietetic phospholipid compositions and use thereof as a dietary supplement |
| 01/04/1996 | WO1995033467A3 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
| 01/04/1996 | WO1995033464A3 Retroviral protease inhibitor combinations |
| 01/04/1996 | WO1995033456A3 Reducing intraocular pressure using aryloxy- and aryl-acetic acids |
| 01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |
| 01/04/1996 | DE4428152A1 Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung New amido quinoxalinediones, their preparation and use |
| 01/04/1996 | DE4423078A1 Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung Carbamazepine sustained release dosage form |
| 01/04/1996 | CA2193799A1 Dopamine d1 agonists for the treatment of dementia |
| 01/04/1996 | CA2193725A1 Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity |
| 01/04/1996 | CA2193695A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 01/04/1996 | CA2193397A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 01/04/1996 | CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof |
| 01/04/1996 | CA2193221A1 Combination therapy for hiv infection |
| 01/04/1996 | CA2192855A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 01/04/1996 | CA2192711A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 01/04/1996 | CA2191726A1 Non-antigenic amine derived polymers and polymer conjugates |
| 01/04/1996 | CA2187332A1 Tacrine pharmaceutical compositions |
| 01/04/1996 | CA2170400A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors |
| 01/04/1996 | CA2170136A1 Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects |
| 01/03/1996 | EP0690131A1 Non-reducing saccharide and its production and use |
| 01/03/1996 | EP0690130A1 Saccharide composition with reduced reducibility, and preparation and uses thereof |
| 01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/03/1996 | EP0690070A1 Indole-containing peptide and process for preparing the same |
| 01/03/1996 | EP0690066A1 Phosphinic acid derivatives, their preparation as well as their use |
| 01/03/1996 | EP0690056A2 Process for the preparation of purins |
| 01/03/1996 | EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors |
| 01/03/1996 | EP0690049A2 Agent for treating hepato biliary diseases |
| 01/03/1996 | EP0690048A1 Ortho-amino substituted benzoylguanidines, process for their preparation, their use as medicine or diagnostic and medicines containing them |
| 01/03/1996 | EP0689845A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 01/03/1996 | EP0689842A1 Use of an organic extract of cinnamon plant to inhibit growth of helicobacter pylori |
| 01/03/1996 | EP0689841A1 Powder preparation for healing damaged skin |
| 01/03/1996 | EP0689839A2 Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide |
| 01/03/1996 | EP0689838A1 Use of diadenosine 5', 5'''- p1, p4 - tetraphosphate for curing ischemic anyocardial disease |
| 01/03/1996 | EP0689837A2 Anti-hyperglycemic medicaments |
| 01/03/1996 | EP0689836A1 Spirooxathiolane-quinuclidine derivative for the treatment of xerostomia |
| 01/03/1996 | EP0689832A2 Antibiotic preparation for aural application |
| 01/03/1996 | EP0689767A2 Skin disinfecting formulations |
| 01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |
| 01/03/1996 | EP0689549A1 New urea derivates, their preparation and their use |
| 01/03/1996 | EP0689546A1 Macrocyclic carbamate immunomodulators |
| 01/03/1996 | EP0689545A1 Macrocyclic amide and urea immunomodulators |
| 01/03/1996 | EP0689544A1 Process for production of an imidazole derivative |
| 01/03/1996 | EP0689540A1 Carbacephalosporin compound, their preparation and use |
| 01/03/1996 | EP0689539A1 Antipsychotic indazole derivatives |
| 01/03/1996 | EP0689538A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 01/03/1996 | EP0689537A1 Method and apparatus for extracting taxol from source materials |
| 01/03/1996 | EP0689536A1 Naphthalene derivatives |
| 01/03/1996 | EP0689535A1 Benzimidazole derivatives |
| 01/03/1996 | EP0689534A1 Amide derivatives as 5-ht 1a? ligands |
| 01/03/1996 | EP0689460A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
| 01/03/1996 | EP0689458A1 Active-substance patch for releasing estradiol to the skin |
| 01/03/1996 | EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/03/1996 | EP0689446A1 Drugs for the treatment of retrovirus infections |
| 01/03/1996 | EP0689445A1 Aluminium containing pharmaceutical preparation with controlled release |
| 01/03/1996 | EP0689444A1 Tylosin containing sustained release veterinary compositions |
| 01/03/1996 | EP0689443A1 The use of bisphosphonates in bone surgery |
| 01/03/1996 | EP0689442A1 Nasal pharmaceutical composition containing a progestational agent |
| 01/03/1996 | EP0689441A1 Pharmaceutical composition in the form of a kit |
| 01/03/1996 | EP0689440A1 Use of triazine compounds as anxiolytics |
| 01/03/1996 | EP0689439A1 Use of triazine compounds for the treatment of memory and learning disorders |
| 01/03/1996 | EP0689438A1 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/03/1996 | EP0689437A1 Use of granisetron for the treatment of post-operative nausea and vomiting |
| 01/03/1996 | EP0689436A1 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 01/03/1996 | EP0689435A1 Use of substituted alkyl nitrates for the treatment of pathologically increased intra-ocular pressure |
| 01/03/1996 | EP0689434A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 01/03/1996 | EP0689432A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols |
| 01/03/1996 | EP0689431A1 New use of anti-acne agents |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0689427A1 Water dispersible therapeutic compounds |
| 01/03/1996 | EP0689426A1 Therapeutic agent for the treatment of melanomas |
| 01/03/1996 | EP0689424A1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| 01/03/1996 | EP0689418A1 Deodorant active-substance combinations made from wool-grease acids and partial glycerides |
| 01/03/1996 | EP0619806B1 Preparation of substituted piperidines |
| 01/03/1996 | EP0605742A4 Agent with adaptogenic activity. |